AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2023
May 5, 2023
284_dirs_2023-05-04_b29d336f-0e2d-472f-b372-2579e997071a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-05-02
Reporting Person: Williams David Michael (EVP,Chief Info&Digital Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-02 | Stock Option (Right to Buy) | $117.89 | A | 19364 | Acquired | 2033-05-01 | Common Stock (19364) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11058.96 | Direct |
Footnotes
F1: The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30